Changes in HER3 expression profiles between primary and recurrent gynecological cancers

Changes in HER3 expression profiles between primary and recurrent gynecological cancers

Abstract Background Human epidermal growth factor receptor-3 (HER3) is a member of the epidermal growth factor receptor family of receptor tyrosine kinases, and its overexpression is associated with inferior prognosis in several cancers. However, it is unclear whether HER3 expression status changes...

Full description

Bibliographic Details
Main Authors: Yuki Kojima, Kazuki Sudo, Hiroshi Yoshida, Shu Yazaki, Momoko Tokura, Chiharu Mizoguchi, Hitomi S. Okuma, Shosuke Kita, Kasumi Yamamoto, Tadaaki Nishikawa, Emi Noguchi, Tatsunori Shimoi, Yasuhito Tanase, Masaya Uno, Mitsuya Ishikawa, Tomoyasu Kato, Kumiko Koyama, Maki Kobayashi, Tomoya Kakegawa, Yasuhiro Fujiwara, Kan Yonemori
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Cancer Cell International
Subjects:
HER3
Ovarian cancer
Endometrial cancer
Cervical cancer; biomarker
Online Access:https://doi.org/10.1186/s12935-022-02844-z

Internet

https://doi.org/10.1186/s12935-022-02844-z

Similar Items